Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

OpenEvidence Wide-Releases AI-Integrated Doctor Dialer™, for Privacy-Centric, Doctor-Patient Telemedicine Calls, Messaging, and Voicemail in One Unified Clinical Platform--With Live Clinical Decision AI Deeply-Integrated.

Dialer logo

News provided by

OpenEvidence

Feb 26, 2026, 10:15 ET

Share this article

Share toX

Share this article

Share toX

The limited release version of OpenEvidence's doctor-patient Visits™ suite has already been used to power ~37 million minutes of doctor-patient care communications and interactions in the United States in just the last several months since limited release.

MIAMI , Feb. 26, 2026 /PRNewswire/ -- OpenEvidence, the most valuable doctor technology company in the world, whose clinical decision AI was named "the best AI tool for medical information" by the New England Journal of Medicine JW—and which is used (according to independent studies) by more American doctors than all other AIs in the world combined—today announced the wide-release and expansion of the OpenEvidence AI-Integrated Doctor Dialer™—a HIPAA-secure, privacy-centric communications suite purpose-built for doctor-patient telemedicine calls, messaging, faxing, and straight-to-voicemail outreach, all delivered natively inside the OpenEvidence app as one unified clinical platform.

Continue Reading
Dialer_faxing
Dialer_faxing
Dialer_INTRO
Dialer_INTRO

The OpenEvidence AI-Integrated Doctor Dialer™ is built on multi-step AI that operates throughout the entire clinical workflow—from call documentation to real-time clinical decision support during the patient call—with evidence-based recommendations embedded directly within the patient notes generated from the call. This ensures AI assistance is available at every step of the patient call, visit, and communication.

Unlike traditional standalone dialers and fragmented "communications add-ons," the OpenEvidence AI-Integrated Doctor Dialer™ is designed to make high-stakes clinical communications with patients more efficient and more accurate by embedding OpenEvidence's world-leading Clinical Decision AI—used by more American doctors than all other AIs combined—directly into the patient communications workflow—so clinicians can communicate, document, and navigate next-step clinical decisions with deeply-integrated, real-time AI decision support—even on privacy-centric telemedicine calls and other communications with patients.

Even the limited release version of OpenEvidence's doctor-patient Visits™ suite—which was only available to select users prior to today—has already been used to power ~37 million minutes of doctor-patient care communications and interactions in the United States—in just the last several months since limited release.

The OpenEvidence Dialer was originally designed to address a common challenge for clinicians—choosing between personal privacy and patient accessibility—the OpenEvidence Dialer enables healthcare professionals to communicate with patients securely while keeping their personal phone numbers private.

With the OpenEvidence Dialer, clinicians can:

  • Place calls with customizable caller ID number set to their hospital or practice, increasing patient pickup rates while maintaining personal privacy.
  • Make sure calls are answered with custom caller ID
  • Connect with patients over telemedicine in one tap
  • Switch seamlessly between profiles and phone numbers across multiple hospitals or clinics, and boost pickup rates by ensuring your patients see the right caller ID number when you call.
  • Send and receive secure text messages directly within the OpenEvidence app, with optional patient replies.
  • Send and receive faxes by uploading files or scanning documents in-app.
  • Deliver straight-to-voicemail messages without ringing the patient's phone—ideal for appointment reminders, follow-ups, and other non-urgent communications.
  • Automatically create clinical notes by selecting "Create Visit," which transcribes patient calls into structured documentation with real-time evidence integration. Your patient communication, clinical decision support, and documentation are all in one place.

All communications remain fully HIPAA-compliant. By unifying patient communication, clinical decision support, and documentation into a single workflow, OpenEvidence eliminates the need for fragmented tools and disconnected systems.

The OpenEvidence Dialer includes unlimited daily minutes and is free for all verified U.S. healthcare professionals. It is available today within the OpenEvidence app—simply tap "Dialer" on the navigation bar to get started.

About OpenEvidence

Named "the best AI tool for medical information" by the New England Journal of Medicine JW, independent studies show that OpenEvidence is used by more American doctors than all other AIs in the world—combined.  OpenEvidence is a clinical decision support platform built to help healthcare professionals access real-time, evidence-based answers and streamline clinical workflows—all within a secure, HIPAA-compliant environment. OpenEvidence is currently the most valuable doctor technology company in the world, and is backed by Google, Nvidia, Sequoia—and all of the other leading investors in the world. 

About OpenEvidence AI-Integrated Doctor Dialer™

OpenEvidence AI-Integrated Doctor Dialer™ is available on the OpenEvidence app for iOS and Android, and enables HIPAA-secure, privacy-centric calling, messaging, faxing, and straight-to-voicemail capabilities directly within the OpenEvidence app. The OpenEvidence Dialer allows you to call patients with the caller ID number set to your desired hospital or practice number, keeping your personal phone number private. The Dialer also optionally integrates with OpenEvidence Visits™, allowing you to automatically create a quick clinical note from the call. The Dialer is accessible directly in the OpenEvidence app, available today.

Media Contact:
[email protected] 

SOURCE OpenEvidence

21%

more press release views with 
Request a Demo

Modal title

Also from this source

OpenEvidence Achieves Historic Milestone: 1 Million Clinical Consultations between Verified Doctors and an Artificial Intelligence System in a Single Day

OpenEvidence Achieves Historic Milestone: 1 Million Clinical Consultations between Verified Doctors and an Artificial Intelligence System in a Single Day

On March 10, 2026, for the first time in history, one million clinical consultations were conducted between NPI verified physicians and an AI system, ...

OpenEvidence Acquires Google Ventures-Backed AI Startup, Amaro

OpenEvidence Acquires Google Ventures-Backed AI Startup, Amaro

OpenEvidence announced today its acquisition of Amaro, an AI-native advertising company founded by Kush Khosla and Sauren Khosla and backed by Google ...

More Releases From This Source

Explore

Artificial Intelligence

Artificial Intelligence

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

Telecommunications Industry

Telecommunications Industry

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.